The expression of estrogen receptor alpha (ERa) is generally associated with a less invasive and aggressive phenotype in breast carcinoma. In an attempt to understand the role of ERa in regulating breast cancer cells invasiveness, we have demonstrated that cell adhesion on fibronectin (Fn) and type IV Collagen (Col) induces ERamediated transcription and reduces cell migration in MCF-7 and in MDA-MB-231 cell lines expressing ERa. Analysis of deleted mutants of ERa indicates that the transcriptional activation function (AF)-1 is required for ERa-mediated transcription as well as for the inhibition of cell migration induced by cell adhesion on extracellular matrix (ECM) proteins. In addition, the nuclear localization signal region and some serine residues in the AF-1 of the ERa are both required for the regulation of cell invasiveness as we have observed in HeLa cells. It is worth noting that c-Src activation is coincident with adhesion of cells to ECM proteins and that the inhibition of c-Src activity by PP2 or the expression of a dominant-negative c-Src abolishes ERa-mediated transcription and partially reverts the inhibition of cell invasiveness in ERa-positive cancer cells. These findings address the integrated role of ECM proteins and ERa in influencing breast cancer cell motility through a mechanism that involves c-Src and seems not to be related to a specific cell type.
Introduction
Several clinical studies have demonstrated that estrogen receptor alpha (ERa)-positive tumors have lower metastatic potential than ERa-negative tumors (Fraker et al., 1984; Osborne et al., 1985; McGuire, 1986; Price et al., 1990) . Many reports correlate ERa expression to lower matrigel invasiveness and to a reduced metastatic potential of breast cancer cell lines (Liotta et al., 1991; Thompson et al., 1992; Rochefort et al., 1998) ; however, the molecular mechanisms that define this process are still unclear. The interaction of cells with the extracellular matrix (ECM) influences many aspects of cell behavior, including growth, morphology, migratory properties and differentiation (Hynes, 1990; Clark and Brugge, 1995; Giancotti and Ruoslahti, 1999) . The adhesion to ECM is mediated by integrin receptors that are reported to control growth factor signaling pathways. Specifically, cells adherent to ECM show an enhanced activation of the p42 and p44 forms of the mitogen-activated protein kinase (MAPK) (Miyamoto et al., 1996; Lin et al., 1997; Renshaw et al., 1997; Aplin and Juliano, 1999) . In addition, binding of the integrin receptor with ECM proteins causes a direct transient activation of MAP kinase in the absence of growth factors (Chen et al., 1994; Schlaepfer et al., 1994; Zhu and Assoian, 1995) .
The transcriptional activation function (AF)-1 of the N-terminal ERa is a target of various protein kinases such as MAPK, PI3-k, Akt and c-Src, which are activated by growth factor pathways, either in the presence or in the absence of 17b-estradiol (E 2 ) (Power et al., 1991; Chalbos et al., 1993; Aronica et al., 1994; Kato et al., 1994; Couse et al., 1995; Ignar-Trowbridge et al., 1995; Bunone et al., 1996; Weigel, 1996; Joel et al., 1998) . c-Src is also one of the first protein kinases activated by cell adhesion to ECM (Guan, 1997; Schlaepfer et al., 1997; Schaller et al., 1999) and it has been shown to play a significant role in several phases of outside-in signaling in many cell types (Kaplan et al., 1995; Lowell et al., 1996; Suen et al., 1999) . The overexpression and activation of Src family kinases have been identified in a range of human cancers (Irby and Yeatman, 2000) and these have been indicated to contribute not only to the growth and survival of breast cancer cells but also to increase their metastatic potential (Summy and Gallick, 2003) .
In this study, we have tested the hypothesis that cell adhesion on ECM modulates ERa transcriptional activity, producing a reduction of cell migration. Our results show that estrogen receptor activation function 1 (AF-1)/ERa is an effector of the adhesion protein signals. Cell adhesion on Fibronectin (Fn) and type IV collagen (Col) induces the transcriptional activation of ERa and the reduction of cell migration in MCF-7 cells, as well as in MDA-MB-231 and in HeLa cells both engineered to express ERa. In addition, we have found that c-Src is essential for ERa activation in response to cell adhesion. Focusing on the relationship between c-Src activity and ERa expression in breast cancer cells, we have shown that the transactivation of ERa upon cell adhesion on ECM proteins counteracts the action of cSrc on cell motility and invasiveness in cancerous cells.
Results

Cell adhesion on Fn or Col induces ERa translocation into the nuclear compartment
First, we determined whether cell adhesion on either Fn or Col may influence ERa expression. MCF-7 cells, serum-starved for 24 h, were plated onto Fn-, Col-and P-Lys-(negative control) coated dishes and incubated for 30 min, 1 h, 4 h and 8 h. Equal amounts of cytosolic and total (nuclear þ cytosolic) protein lysates were resolved by SDS-PAGE and analysed by Western blot for ERa detection. Figure 1b shows a significant decrease of ERa content in the cytosol 30 min to 4 h after cell adhesion on Fn and Col with respect to the control reported in Figure 1a . No substantial changes in total ERa content were observed in our time course study (Figure 1b) . These results support the conclusion that cell adhesion on either Fn or Col induced a translocation of ERa into the nuclear compartment. The observed compartmentalization of ERa was confirmed by immunocytochemistry using MCF-7 cells maintained in a serum-free medium for 96 h, then detached, plated onto Fn-, Col-and P-Lys-coated slides and incubated for 2 h (Figure 1c) . No signal was detected in the control cells (P-Lys); this may be due to the binding of ERa with chaperon proteins that possibly mask the epitope for the ERa antibody.
Fn and Col induce estrogen-responsive element (ERE) transcription
Since Fn and Col were able to translocate ERa into the nuclear compartment, we evaluated their ability to induce ERa-mediated transcription. MCF-7 cells were transfected with the ERE responsive reporter plasmid (XETL) and the pRL-Tk plasmid expressing Renilla luciferase, as an internal control. The cells were then serum starved for 24 h and exposed to E 2 , Fn, Col or P-Lys before luciferase assays. Figure 2a shows a significant increase in EREmediated transcription induced by both Fn and Col in the absence of ER ligand. In contrast, P-Lys failed to induce ERa-mediated transcription, showing that the observed effect is specifically due to the integrin substrates.
The same results were obtained in MDA-MB-231 cells transiently expressing ERa and the reporter gene, suggesting that the Fn/Col-induced transcriptional activation is specifically mediated by ERa (Figure 2c) . A slight but significant increase in luciferase expression was observed in wild-type MDA-MB-231 treated with both Fn and Col (Figure 2b ), probably due to the expression of ERb (Lazennec et al., 2001 ), as we detected in the present study (data not shown). The antiestrogen ICI reversed this upregulatory effect induced by both ECM proteins in all the experimental conditions and in both cell lines.
In addition, no substantial differences were observed in luciferase expression when transfected MCF-7 and MDA-MB-231 were plated onto both Fn-and Colcoated dishes (data not shown).
ERE-mediated transcription induced by Fn and Col upregulates pS2 and cathepsin D mRNA
Owing to their ability to induce ERE-mediated transcription, Fn and Col were assessed for their capacity to regulate the expression of endogenous ERa-specific target genes as pS2 ( Figure 3a ) and cathepsin D (Figure 3b ). Figure 1 Cell adhesion on Fn or Col induces ERa translocation into the nuclear compartment. (a) MCF-7 cells serum-starved for 24 h were detached and an aliquot was lysed and used as control (time 0); (b) a further aliquot was plated in PRF-SFM on P-Lys-(2 mg/ cm 2 ), Fn-(30 mg/ml) or Col-(30 mg/ml) coated dishes. After 30 min, 1 h, 4 h and 8 h of incubation, cytosolic (Cyt) and total (cytosolic and nuclear) (Tot) protein lysates were subjected to Western blotting with an anti-ERa monoclonal antibody. These results are representative of five independent experiments. (c) MCF-7 cells serum starved for 96 h were detached and plated in PRF-SFM on PLys-(2 mg/cm 2 ), Fn-(30 mg/ml) and Col-(30 mg/ml) coated slides or plated on culture-treated slide and incubated with E 2 (10 nM). After 2 h, cells were fixed, probed with anti-ERa antibody and stained as described in Materials and methods
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The results show the ability of Fn and Col, but not of P-Lys, to upregulate both pS2 and cathepsin D mRNAs.
Fn and Col induce ERE-mediated transcription through AF-1 activation Subsequently, we questioned which functional domain of ERa was affected by the adhesion protein signals. To exclude the influence of specific factors present in breast cancer cells, we transiently cotransfected HeLa cells with MDA-MB-231 were also cotransfected with 0.3 mg/well HeG0 and 0.6 mg/well of XETL (c). Cells were incubated in the transfection cocktail for 6 h, serum starved for an additional 24 h and then incubated for 16 h in PRF-SFM (untreated) or in PRF-SFM containing either 10 nM estradiol (E 2 ), 30 mg/ml Fn, 30 mg/ml Col or 15 mg/ml P-Lys. The same treatments were also carried out in the presence of 100 nM ICI 182,780. Firefly luciferase activity was internally normalized to R. luciferase and expressed as fold of increase with respect to the PRF-SFM (untreated) (Figure 4b ) coding for the carboxyl-terminal and amino-terminal truncated receptor, respectively. The treatment with either E 2 or Fn and Col leads to an increase of luciferase activity in HeLa cells expressing ERa corresponding to that observed in MCF-7 (data not shown). Both ECM proteins induced ERE-mediated transcription only in HeLa cells transiently expressing the AF-1/DBD domains of ERa (Figure 4a ), while the treatment with E 2 gave a significant increase of ERE-mediated transcription when the AF-2/DBD domains of ERa were expressed (Figure 4b ). ICI abolished the upregulatory effects induced by Fn, Col and E 2 , while 4-OH tamoxifen (4OH-Tam) treatment was able to negatively interfere only with E 2 -induced activation in cells expressing either ERa (data not shown) or the AF-2/ DBD domains of ERa. In summary, these data demonstrate that either Fn or Col is able to activate ERa by targeting the AF-1 domain.
Fn and Col activate ERa through c-Src
On the basis of previous findings demonstrating that cSrc is activated by Fn (Schlaepfer et al., 1997) and that ERa is activated in its AF-1 domain by signals transduced from c-Src (Feng et al., 2001) , we questioned whether c-Src might be involved in ERa activation induced by cell adhesion/treatment to Fn and Col. We investigated the role of c-Src in MCF-7 cells transfected with pcDNA3 as control vector, c-Src( þ ) and c-Src(À) (dominant negative of c-Src) ( Figure 5a ). The overexpression of c-Src potentiates ERa transactivation both in basal condition as well as upon E 2 , Fn and Col exposure. The expression of the dominant-negative c-Src as well as the treatment with PP2-abrogated EREmediated transcription induced by both Fn and Col, however, only attenuated the response to E 2 . Altogether, these data suggest that c-Src is required for ERa activation by signals derived from cell adhesion to ECM. Under the same experimental conditions, we evaluated the autophosphorylation of c-Src and the phosphorylation of the exogenous substrate enolase (Figure 5b ) after 5 min of exposure. The indicated time was chosen after a time course study (here not reported) performed at 0, 5, 10 and 20 min displaying the maximal enzymatic activity at 5 min. The results provide evidence that both E 2 , Fn and Col activate c-Src, while either the expression of a dominant-negative c-Src or the presence of PP2 strongly reduces both the autophosphorylation of c-Src and the phosphorylation of enolase.
E 2 , Fn and Col reduce cell motility
Since previous studies have shown that ERa expression leads to a lower matrigel invasiveness and to a reduced metastatic potential in breast cancer cells Platet et al., 2000) , we investigated whether Figure 4 Fn and Col induce ligand-independent transcriptional activation of the ERa. HeLa cells were transfected with 0.3 mg/well HE15 and 0.6 mg/well XETL (a) or with 0.3 mg/well HE19 and 0.6 mg/well XETL (b). At 6 h after transfection cocktail addition, cells were shifted in PRF-SFM for 24 h and then incubated for 16 h in PRF-SFM containing either 15 mg/ml P-Lys, 10 nM estradiol (E 2 ), 30 mg/ml Fn or 30 mg/ml Col. The same treatments were also carried out in the presence of 100 nM 4-OH Tam and 100 nM ICI 182,780. Firefly luciferase activity was internally normalized to R. luciferase and expressed as fold of increase with respect to the PRF-SFM (untreated) samples. Results represent the mean7s.d. of five independent experiments.
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Fn and Col induce ERa activation D Sisci et al the activation of ERa by both ECM proteins was correlated with the motility of breast cancer cells. MCF-7, MDA-MB-231 and HeLa cells were used to evaluate cell invasion on Transwell chambers previously coated with Fn, Col or P-Lys and incubated overnight in PRF-SFM or in PRF-SFM containing E 2 . In agreement with previous studies , E 2 treatment produced a marked reduction of cell migration in MCF-7 ( Figure 6a ) as well as in both MDA-MB-231 (data not shown) and HeLa cells expressing ERa (Figure 6b ). Similar inhibition was observed after cell adhesion to either Fn or Col. To further clarify the contribution of the two ERa/AF domains in regulating cell motility, HeLa cells were transfected with either the AF-1-or AF-2-deleted constructs and plated onto transwells coated with both ECM proteins. Cells expressing the AF-1/ DBD domains ( Figure 6c ) showed a strong reduction of cell invasion induced by both ECM proteins and reversed by ICI (data not shown). In contrast, only E 2 treatment reduced cell migration when the AF-2/DBD domains of the ERa were expressed (Figure 6d ).
Fn and Col reduce cell motility through c-Src in breast cancer cells expressing ERa
Having established the role of c-Src in mediating ERa activation induced by cell adhesion to both Fn and Col, we examined its involvement in the regulation of breast Figure 5 Fn and Col activate unliganded-ERa through c-Src. (a) MCF-7 cells were cotransfected with calcium phosphate precipitation method using 0.5 mg/well of XETL and 0.5 mg/well of pCMV empty vector or 0.5 mg/well of XETL plasmid with 0.5 mg/ well of c-Src( þ ) or 0.5 mg/well of c-Src(À). At 6 h after transfection, cells were serum starved for 24 h and then incubated for 16 h in PRF-SFM (untreated) or PRF-SFM containing either 10 nM estradiol (E 2 ), 30 mg/ml Fn, 30 mg/ml Col or 15 mg/ml P-Lys. The same treatments were also carried out in the presence of 3 mM of PP2. Firefly luciferase activity was internally normalized to R. luciferase and expressed as fold of increase with respect to the PRF-SFM (untreated) sample. Results represent the mean7s.d. of five independent experiments. The inset pictures present the expression of c-Src and were assessed by Western blotting as described in Materials and methods using 30 mg of total cell lysates. (b) MCF-7 cells, transfected and treated as before for 5 min, were lysed and immunoprecipitated with an anti c-Src antibody/protein A/G complex and assayed for c-Src-kinase activity using acid-treated enolase as described in Materials and methods. These results are representative of three independent experiments. In MCF-7 (Figure 6a ), the presence of either c-Src inhibitor or dominant-negative c-Src partially reverses the decrease in cell invasion caused by cell adhesion on both ECM proteins and, to a lesser extent, by E 2 . In agreement with previous reports (reviewed in Summy and Gallick, 2003) , the inhibition of c-Src elicits a slight decrease in both cell motility and invasiveness of about 20% (Po0.05) in wild-type HeLa cells (data not shown), while the ectopic expression of ERa induces a strong reduction in cell motility (Figure 6b ), which appears emphasized by the adhesion on both ECM proteins, and is partially reversed by the inhibition of cSrc. Under the same circumstances, the dramatic reduction induced by E 2 still persists. Finally, the inhibition of c-Src with PP2 or the dominant-negative c-Src partially reverts the decrease on cell invasion induced by both ECM proteins in HeLa cells expressing the AF-1/DBD domains (Figure 6c ). These data clearly show that c-Src is required for ligand-independent ERamediated reduction of breast cancer cell invasion.
Relationship between ERa and c-Src in mediating cell motility
It was previously demonstrated that elevated expression and/or activity of c-Src drastically increases motility, invasiveness and the metastatic potential of cancerous , after 6 h cells were serum starved for 24 h, detached, plated and allowed to migrate for 16 h on membranes coated either with 2 mg/cm 2 P-Lys (&) or 30 mg/ml Fn ( ) or 30 mg/ml Col (') or treated with 10 nM estradiol ( ). The effects induced by P-Lys, Fn, Col and E 2 on cell motility were also evaluated upon exposure to 3 mM PP2. Cells were then fixed, stained and the cells that migrated to the lower surface of the membranes were counted. The results represent the mean7s.d. of four independent experiments. Po0.001 vs P-Lys; Po0.001 vs the homologues samples in vectors; (Summy and Gallick, 2003) . To further clarify the role of ERa and c-Src in regulating cell motility, we transfected MDA-MB-231 with both HeG0 and Y527F, a constitutively active c-Src (Figure 7) . The different levels of c-Src ectopically expressed in MDA-MB-231 cells does not induce substantial changes in cell motility, while the concomitant expression of ERa is sufficient to reduce cell motility. Namely, when ERa and active c-Src were expressed in a 4 : 1 ratio, a stronger reduction of cell motility was observed with respect to that obtained in cells expressing ERa alone. However, when MDA-MB-231 were transfected with ERa/c-Src using a 1 : 4 ratio, the reduction was partially reversed. These results indicate an opposite role for ERa and c-Src activity in regulating cell motility.
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Nuclear localization of ERa is required to inhibit cell motility
Next, we questioned whether the nuclear localization of ERa is required for the reduction of cell invasion. With this aim, we tested cell invasion in HeLa cells transfected with either ERa or ERa in which serine 104, 106 and 118 were replaced by alanine residues (ER/Ser/A) and with the ERa lacking the NLS domain (E241G) in the presence of E 2 , Fn and Col. In HeLa cells expressing the wild-type ERa E 2 , Fn and Col induced a functional Figure 7 Relationship between ERa and c-Src in the regulation of cell motility. MDA-MB-231 cells were transfected, by calcium phosphate DNA co-precipitation method, using HeG0 and Y527F in a 4 : 1 or 1 : 4 ratio. The same plasmids were transfected either with pcDNA3 or pSG5 as vector of Y527F and HeG0, respectively. At 6 h after transfection, cells were serum starved for 24 h and then detached, counted and plated onto porous membranes in DMEM/ F12 þ 5% CS for 16 h. Cells were then fixed and stained, and cells which migrated to the lower surface of the filters were counted. The inset picture presents the expression of both ERa and c-Src in MDA-MB-231 cells after transfection. ERa and c-Src expression was assessed by Western blot as described in Materials and methods using 20 mg of total cell lysates. A measure of 20 mg MCF-7 cell lysates was used as positive control. The results represent the mean7s.d. of three independent experiments. Po0.01 vs vectors,
Po0.05 vs vectors
Figure 8 NLS and the AF-1 domain of ERa are required for liganddependent and -independent regulation of cell migration. HeLa cells were transfected with either HeG0 (&) or ER/Ser/A ( ) or E241G (') by the calcium phosphate DNA co-precipitation method. After 6 h, cells were serum starved for 24 h and then detached and plated onto porous membranes coated either with 2 mg/cm 2 P-Lys, 30 mg/ml Fn (Fn), 30 mg/ml Col (Col) or treated with 10 nM estradiol (E 2 ) and incubated for 16 h, allowing cells to migrate. Cells were then fixed, stained and cells which migrated to the lower surface of the filters were counted (a). The inset picture presents the expression of ERa by Western blot after transfection (b). In the same experimental conditions, HeLa cells were co-transfected with either 0.3 mg/well HeG0, ER/Ser/A, E241G plus 0.6 mg/well of XETL (c). (Figure 8c ). In the presence of ER/Ser/A, only E 2 induced a slight functional transactivation of ERa (Figure 8a ), while none of the treatments produced substantial effects on cell invasiveness (Figure 8c ). In HeLa cells expressing ERa deleted in the NLS region, the functional transactivation of ERa was abolished (Figure 8a ), while just a slight decrease of cell invasiveness was observed after the cells adhesion on membranes coated with Fn and Col (Figure 8c ).
Discussion
Several previous studies have indicated an important role for E 2 in decreasing 'in vitro' invasiveness and motility of ERa-positive breast and ovarian cancer cells (Thompson et al., 1992; Hayashido et al., 1998; Rochefort et al., 1998) . We found that cell adhesion on Fn and Col induces ERa translocation from the cytoplasm into the nucleus increasing the expression of estrogen-responsive genes, such as PS2 and cathepsin D, together with a downregulation of cell motility and invasion. Using ERa mutants lacking the AF-1 or the AF-2 region, we have provided evidence that both Fn and Col activate ERa in a ligand-independent manner as efficiently as the AF-2/ ERa-mediated transcription induced by E 2 . It has been well documented that human ERa is phosphorylated by c-Src in vitro (Arnold et al., 1995) and that breast tumors, exhibiting an enhanced c-Src activity, frequently express a progesterone receptor. These findings raise the possibility that Src family kinases may contribute to the hormone dependence of tumor cell growth (Lehrer et al., 1989) . In the same scenario, c-Src is able to transactivate the AF-1 domain of unliganded ERa partly through the ERK1/ERK2 signaling cascade and partly through the JNK signaling cascade (Feng et al., 2001) .
Cell adhesion to ECM proteins induces the recruitment and activation of the FAK/c-Src kinase complex, which may be a crucial step in integrin-mediated signal transduction processes (Chen et al., 1994; Schlaepfer et al., 1994; Morino et al., 1995; Schlaepfer and Hunter, 1996) . These findings well suit our data demonstrating that c-Src is activated by cell adhesion on both Fn and Col, leading to the functional transactivation of ERa with a concomitant reduction of cell invasion. Both ERa transactivation and the reduction of cell invasion, caused by both ECM proteins, were reversed by either PP2 or the expression of a dominant-negative c-Src. However, E 2 is still able to activate ERa with a reduction in cell invasion. These data strengthen previous findings demonstrating the existence of two distinct mechanisms through which ERa inhibits breast cancer cell motility according to its unliganded or liganded status (Platet et al., 2000) . The ability of both ECM proteins to transactivate ERa via c-Src is not linked to specific factors present in breast cancer cells since it was reproduced in HeLa cells engineered to express ERa, ERb (data not shown) and ERa deleted in the AF-2 domain. The expression of either ERa or AF-1/ERa is sufficient to reduce cell invasion that results enhanced by cell interactions with both Fn and Col. These data, taken together, address how A/B region of ERa is crucial for both ligand-independent transcriptional activation and the reduction of cell invasion induced by the two ECM proteins, thus confirming that the AF-2 domain may be dispensable for hormoneindependent inhibition of cell invasiveness and motility (Platet et al., 2000) .
C-Src is an effector of multiple protein tyrosine kinase signals, particularly active during the process of tumorigenesis (Summy and Gallick, 2003) . For instance, the enhanced expression of c-Src in cells expressing elevated levels of EGF-R resulted in increased DNA synthesis, soft agar growth and tumor formation in nude mice (Maa et al., 1995) . The sustained activation of c-Src, observed in mammary epithelial cells overexpressing Erb-B2 (Sheffield, 1998) and in TGF-a-induced mammary tumor cell line (Amundadottir and Leder, 1998) , enhances the anchorage-independent growth of these cells. Activated c-Src in mammary tumors has been well studied in transgenic mice. Mice expressing viral polyoma middle T antigen under the control of the MMTV promoter produce highly metastatic mammary tumors with elevated c-Src kinase activity (Guy et al., 1994) . Besides, mice overexpressing the neu oncogene also develop mammary tumors with 6-8-fold higher c-Src kinase activity than the adjacent normal tissue . Thus, it appears from the above reported findings that c-Src lies at the hub of a very complex network of signaling pathways, which integrate a variety of intracellular and extracellular events. Part of this network links the adhesion proteins to ERa, leading to the reduction of cell motility. The latter effect appears to be mediated at the nuclear level since it is abrogated in the presence of ERa deleted in the NLS. This strongly suggests that ERa may induce the expression of genes able to enhance cell adhesion and negatively control cell migration.
Importantly, it has been demonstrated that ERa activation upregulates fibulin-1, an Fn-binding ECM protein , while it decreases metalloproteinase 9 (Crowe and Brown, 1999) and type IV collagenase (Abbas Abidi et al., 1997) , producing a decrease of cell migration. In other words, we have defined an autoregulatory loop linking ECM-integrin-FAK-c-Src signals to ERa. The output of this loop is dependent on the delicate balance between c-Src and ERa. However, this balance is distorted during tumorigenesis, resulting in a sustained marked activation of c-Src. When a continued activation on c-Src occurs, the balance of the autoregulatory loop between integrins-FAK-c-Src kinase and ERa may be over-ridden and the effect of constitutive active c-Src in enhancing cell migration and invasiveness becomes dominant. Indeed, we observed that the reduced cell migration induced by ectopic expression of ERa in MDA-MB-231 cells is reversed when c-Src content substantially exceeds that of ERa.
On the basis of our findings, it is reasonable to assume that a coordinate role between ECM proteins and ERa exists in controlling cell motility and cell metastatic potential in ERa-positive breast cancer cells. Even though several substrates of the FAK/c-Src complex have been recently identified (Cary et al., 1998; Klemke et al., 1998; Petit et al., 2000) , the mechanisms whereby c-Src pathways regulate cell migration remain, however, to be fully elucidated.
Materials and methods
Cell lines and cell culture conditions
Two human breast cancer epithelial cell lines, MCF-7 (ER þ ) and MDA-MB-231 (ERÀ) and a cervicae carcinoma cell line HeLa (ERÀ) were used. MCF-7 and MDA-MB-231 cells were maintained in a monolayer culture in Dulbecco's modified Eagle's/Ham's F-12 medium (1 : 1) (DMEM/F12; Eurobio, F) supplemented with 5% calf serum (CS; Eurobio, F), 100 UI/ml penicillin (Eurobio, F), 100 mg/ml streptomycin (Eurobio, F) and 0.2 mM L-glutamine (Eurobio, F). HeLa cells were maintained in monolayer cultures in minimal essential medium (MEM) with Earle's salts (Eurobio, F) supplemented with 10% fetal bovine serum (Eurobio, F), 100 UI/ml penicillin, 100 mg/ml streptomycin and 0.2 mM L-glutamine. Cells were passed weekly using trypsin-EDTA (Eurobio, F) and media were changed every 2 days.
In all experiments, steroids and growth factors were withdrawn from cells, and were grown in phenol red-free DMEM (PRF-SFM; Eurobio, F) containing 0.5% BSA and 2 mM L-glutamine for 24 h.
Western blotting
To establish the influence of both ECM proteins on ERa protein expression, MCF-7 cells, serum starved for 24 h, were detached with versene (Eurobio, F), resuspended in PRF-SFM and plated for 30 min, 1 h, 4 h and 8 h on culture-coated wells with either 30 mg/ml Fn (Sigma, USA) in PBS or 30 mg/ml Col (Sigma, USA) in 10 mM acetic acid or 2 mg/cm 2 poly-L-lysine (P-Lys; Sigma, USA) in PBS. At the end of each incubation time, cells were washed with ice-cold PBS and lysed for 1 min at 41C in Triton lysis buffer (50 mM HEPES (pH 7.5), 150 mM NaCl, 1.5 mM MgCl 2 , 1 mM CaCl 2 , 1% Triton X-100, 0.2 mM Na 3 VO 4 , 1% PMSF, 1% Aprotinin) for the cytosolic lysates and in SDS lysis buffer (62.5 mM Tris-HCl (pH 6.8), 50 mM dithiothreitol, 2% SDS, 10% glycerol, 0.2 mM Na 3 VO 4 , 1% phenylmethyl-sulfonylfluoride) for the total (cytosolic and nuclear) lysates. Cell lysates were cleared by centrifugation (14 000 r.p.m. for 10 min at 41C) and the protein content was determined by the Bradford method. Cellular lysates (20 mg of protein/lane) were resolved by SDS-PAGE, then transferred to nitrocellulose membranes and probed with an ERa monoclonal antibody (F-10 clone; Santa Cruz Biotechnology, USA). The antigen-antibody complexes were detected by incubation of the membranes with peroxidase-coupled antimouse IgG and developed using the ECL Plus Western Blotting detection system (Amersham Pharmacia Biotech, UK).
Immunocytochemical staining
MCF-7 cells, serum starved for 96 h, were detached with versene, resuspended in PRF-SFM and plated either on 30 mg/ ml Fn-, 30 mg/ml Col-or 2 mg/cm 2 P-Lys-coated wells, as described previously, or treated with 10 nM of E 2 . After 2 h of incubation, the cells were fixed with paraformaldehyde (2% PFA for 30 min). Endogenous peroxidase activity was inhibited by hydrogen peroxide (3% in absolute methanol for 30 min) and nonspecific sites were blocked by normal horse serum (10% for 30 min). ERa immunostaining was then performed incubating the primary antibody (F-10 clone) overnight at 41C, while a biotinylated horse-anti-mouse IgG was utilized at room temperature for 1 h as a secondary antibody. Avidin-biotin-horseradish peroxidase complex (ABC/HRP) was applied for 30 min and the chromogen 3-3 0 -diaminobenzidine tetrachloride dihydrate was then used as detection system for 5 min. TBS-T (0.05 M Tris-HCl plus 0.15 M NaCl (pH 7.6) containing 0.05% Triton X-100) served as a washing buffer. The primary antibody was replaced by normal mouse serum at the same concentration in control experiments on MCF-7-cultured cells (not shown).
Plasmids, transfections and ERE-luciferase assay
The reporter plasmid XETL drives the expression of luciferase by an ERE from the Xenopus vitellogenin promoter (Bunone et al., 1996) . The SV40 promoter-based pSG5 vector encoding ERa (wild-type) pSG5-HeG0 (HeG0, Tora et al., 1989) . The two deleted constructs of ERa, pSG5-HE15 and pSG5-HE19, code for a carboxyl-terminal truncated receptor (HE15, amino acids 1-281) and for the amino-terminal truncated receptor (HE19, amino acids 179-575), respectively (a gift from D Picard). The pcDNA3-ER-S104/S106/S118/A is an ERa derivative containing Ser 104, 106 and 118 mutated in Ala inserted in a pcDNA3 expression vector (ER/Ser/A; a gift from DA Lannigan). The pCMV-hE241G is a construct of ERa deleted in the nuclear localization signal (NLS) region (amino acids 250-303) and inserted in the pCMV expression plasmid (E241G; a gift from R Song). The empty expression vector, pCMV, and the same vector containing the c-DNA encoding the wild type of c-Src, pCMV-c-Src (c-Src( þ )), and the dominant negative of c-Src, pCMV-cSrc-K295R,Y527F (c-Src(À)) were gifts from J Brugge and the active form of c-Src, pcDNA3-cSrc-Y527F, (Y527F) was a gift from DD Boyd. The R. reniformis luciferase expression vector used was pRL-Tk (Promega, USA).
To monitor the activation of ERa by ECMs, MCF-7 and MDA-MB-231 cells (5 Â 10 4 density) were plated onto 24-well plates, grown in DMEM/F12 to an approximate confluence of 70-80% and then cotransfected with XETL and pRL-Tk (MCF-7) or XETL, HeG0 and pRL-Tk (MDA-MB-231). All the transfections were carried out using the calcium phosphate DNA co-precipitation method. Cells were transfected in a growing medium and 6 h after transfection were washed twice with PRF-SFM and switched to PRF-SFM for 24 h and then treated for 8 h either with 10 nM E 2 , 30 mg/ml Fn, 30 mg/ml Col or 15 mg/ml P-Lys. The same treatments were carried out in the presence of either 100 nM ICI 182,780 (ICI; Zeneca, UK), 100 nM 4-OH-Tam (Sigma, USA) or 3 mM PP2, an inhibitor of c-Src (Calbiochem, USA). To evaluate which ERa functional domain was involved in ERa activation by ECMs, HeLa cells, cultured and treated as before, were cotransfected with pRL-Tk, XETL and HeG0, HE15 or HE19.
Firefly luciferase and R. reniformis luciferase activities were determined using the Dual Luciferase reporter assay system (Promega, USA) according to the manufacturer's instructions. Firefly luciferase activity was normalized to R. reniformis luciferase activity and expressed as relative luciferase units.
The influence of ERa and c-Src on cell motility was analysed in HeLa cells transfected with HeG0 and Y527F at different concentrations (ratio 1 : 4 and 4 : 1). The same cells were transfected with HeG0 and pcDNA3 or Y527F and pSG5 using the same concentrations mentioned before. To evaluate if ERa acts at the nuclear level in mediating the induced effects of ECM/c-Src on cell motility, MDA-MB-231 cells cultured and treated as before were transfected, as described previously, with ERa mutated in some serine residues (ER/Ser/A, 10 mg/ dish), or with ERa deleted in the NLS (E241G, 10 mg/dish).
RT-PCR
MCF-7 cells were incubated for 24 h in PRF-SFM and then detached and plated on coated or uncoated dishes with either 2 mg/cm 2 P-Lys, 30 mg/ml Fn or 30 mg/ml Col as described previously. The cells plated on uncoated dishes were treated both with and without 10 nM E 2 . After 24 h, total cellular RNA was extracted using RNeasy (Quiagen, USA) and reverse transcribed using Moloney murine leukemia virus (M-MLV) reverse transcriptase (Promega, USA). Briefly, reverse transcription was performed on 1 mg of total RNA in a final volume of 10 ml by incubation at 371C for 30 min with 200 U of M-MLV reverse transcriptase, 0.4 mg oligo-dT, 0.5 mM deoxynucleotidetriphosphate (dNTP) and 24 U RNAsin, followed by heat denaturation for 5 min at 951C.
Subsequent PCR analysis was performed on 1 ml of the RT product in a final volume of 25 ml. (Cat reverse). The amplification of the 408 bp of ribosomal RNA 36B4 was performed as control using the following primers: 5 0 -CTCAACA-TCTCCCCCTTCTC-3 0 (36B4 forward) and 5 0 -CAAATCCCATATCCTCGTCC-3 0 (36B4 reverse). The PCR mixture consisted of 1.25 U GoTaq DNA Polymerase (Promega, USA), 1 Â PCR buffer (10 mM TrisHCl, 50 mM KCl), 2.5 mM MgCl 2 and 0.2 mM each dNTP, 0.6 mM of each PS2 primer and 0.2 mM of each 36B4 primer and 0.6 mM of each cathepsin D primer and 0.2 mM of each 36B4 primer. PCR was performed for 20 cycles at 951C/1 min, 591C/ 2 min and 721C/1 min. A measure of 10 ml of the PCR products were separated on a 1.2% agarose gel.
Immunoprecipitation and kinase activity of c-Src
To assay for c-Src kinase activity MCF-7 cells transfected, as reported in plasmids and transfection section, with c-Src(À), cSrc( þ ) or pcDNA3 were grown in PRF-SFM for 24 h and stimulated with either 15 mg/ml P-Lys, 30 mg/ml Fn, 30 mg/ml Col or E 2 10 nM for 5 min. Another set of cells, transfected with pcDNA3 and treated as before, were incubated with 3 mM PP2. Cells were then lysed with RIPA lysis buffer (500 mM Tris-HCl, 150 mM NaCl, 1% Triton X-100) containing 10 mM PMSF, 1.5 mg/ml aprotinin and 2 mg/ml leupeptin and immunoprecipitated. A Protein G-Agarose and an anti-c-Src antibody complex was prepared to immunopurify the lysates. A measure of 1 mg of mouse monoclonal anti-c-Src antibody (clone 327; Oncogene, USA) and 30 ml of protein G-agarose (Santa Cruz, Biotechnology, USA) were incubated at 41C for 1 h in 500 ml of PBS with a tube rotator. The complexes were microfuged and washed with 1 ml of lysis buffer for three times. At the end, 500 mg of each cell lysates were added to the protein G-agarose/anti-c-Src antibodies and incubated at 41C for 2 h rotating. The proteins/complexes were centrifuged and washed three times with the kinase buffer (200 mM PIPES, 100 mM MnCl 2 ). c-Src kinase activity was assayed by a standard in vitro kinase assay using acidified enolase as substrate. The incubation was performed in a total volume of 50 ml composed of the immunopurified c-Src protein and the kinase buffer containing 5 mM ATP, 1 mC of [g 32 P]ATP and 2.5 mg of acid denatured rabbit muscle enolase (Sigma, USA) as exogenous substrate. Samples were incubated at 301C for 10 min then reduced with an equal volume of 2 Â SDS Laemmli sample buffer (Sigma, USA) and aliquots of them (40 ml) were submitted to SDS-PAGE (acrylamide 11%). The dried gel was exposed to X-omat film (Kodak, USA) for 12 h. All gels were stained with Coomassie blue to ensure that an equal amount of enolase was present in all samples.
Motility assay
To evaluate the role of ERa on cell motility, the following cell lines were used: MCF-7, HeLa and MDA-MB-231 transfected as reported in plasmids and transfections section.
Cells maintained in PRF-SFM for 24 h were dispersed with versene (Eurobio, F), washed twice, resuspended in PRF-SFM and counted using a hemocytometer. The 24-well modified Boyden chambers, containing porous (8 mm) polycarbonate membranes (Costar, USA), were coated, on the internal surface, with either 30 mg/ml Fn, 30 mg/ml Col or 2 mg/cm 2 PLys by incubation at room temperature (Doerr and Jones, 1996) . The lower chambers were loaded with 500 ml of PRF-SFM, while synchronized cells (2 Â 10 4 ) suspended in 200 ml of PRF-SFM with or without 10 nM E 2 and/or 100 nM ICI were plated into upper chambers. Another set of cells, treated as before, was suspended in 200 ml of PRF-SFM with or without 10 nM E 2 and/or 3 mM PP2. After 16 h of incubation in 5% CO 2 at 371C, the cells in the upper chamber were removed by a cotton swab, so that only cells that had migrated through the membrane remained. The membranes were then fixed and stained in Coomassie blue solution (0.25 g Coomassie blue, 45 ml water, 45 ml methanol, 10 ml glacial acetic acid) for 5 min, then each well was rinsed three times with distilled water. The migrated cells were determined using an inverted microscope.
Statistical analysis
All data were expressed as the mean7s.d. (standard deviation) of at least three different experiments. Statistical significances were tested using Student's t-test or paired Student's t-test where appropriate.
Abbreviations AF-1, estrogen receptor activation function 1; AF-2, estrogen receptor activation function 2; Col, type IV collagen; ECM, extracellular matrix; ERa, estrogen receptor alpha; ERb, estrogen receptor beta; Fn, fibronectin; ERE, estrogenresponsive element; c-Src( þ ), c-Src; Src(À), dominant negative of c-Src.
